Skip to main content
EMC Instytut Medyczny S.A. logo

EMC Instytut Medyczny S.A. — Investor Relations & Filings

Ticker · EMC ISIN · PLEMCIM00017 LEI · 2594005WSYZ0JRE8U796 WAR Human health and social work activities
Open in API
Filings indexed 786 across all filing types
Latest filing 2019-09-30 Management Reports
Country PL Poland
Listing WAR EMC

About EMC Instytut Medyczny S.A.

https://www.emc-sa.pl/en

EMC Instytut Medyczny S.A. is a significant operator of private hospitals and outpatient clinics. The company provides comprehensive healthcare services through a network of medical facilities. Its operations are structured into three primary segments: Hospital Care, Outpatient Care, and Clinical Trials. The company offers a wide range of medical specializations, including dermatology, gastroenterology, and immunology. In addition to its core patient care services, EMC Instytut Medyczny is also actively engaged in conducting clinical research.

Recent filings

Filing Released Lang Actions
Sprawozdanie Zarządu z działalności Grupy EMC IM SA - w formacie xml opatrzone podpisami elektronicznymi członków zarządu EMC
Management Reports Classification · 19% confidence
2019-09-30 Polish
e-sprawozdanie w formacie xml - Śródroczne jednostkowe sprawozdanie finansowe EMC IM SA
Interim / Quarterly Report Classification · 19% confidence
2019-09-30 Polish
Sprawozdanie Zarządu z działalności Grupy EMC IM SA
Interim / Quarterly Report Classification · 95% confidence The document is titled 'Sprawozdanie Zarządu z działalności Grupy EMC Instytut Medyczny SA' (Management Report on the activities of the EMC Instytut Medyczny SA Group) for the 6-month period ending June 30, 2019. It contains detailed management commentary, organizational structure, financial highlights, and risk assessments. While it functions as a management report, it is part of the comprehensive interim reporting package for the half-year period. According to the definitions, comprehensive financial reports for periods shorter than a full fiscal year (like half-year reports) are classified as Interim/Quarterly Reports (IR). H1 2019
2019-09-30 Polish
Śródroczne skonsolidowane sprawozdanie finansowe Grupy Kapitałowej EMC IM SA oraz śródroczne skrócone jednostkowe sprawozdanie finansowe EMC IM SA
Interim / Quarterly Report Classification · 100% confidence The document is titled 'ŚRÓDROCZNE SKRÓCONE SKONSOLIDOWANE SPRAWOZDANIE FINANSOWE' (Interim Condensed Consolidated Financial Statement) for the 6-month period ending June 30, 2019. It contains detailed financial statements, including balance sheets, income statements, cash flow statements, and extensive explanatory notes. This fits the definition of an Interim/Quarterly Report (IR) as it provides substantive financial data for a period shorter than a full fiscal year. H1 2019
2019-09-30 Polish
Sprawozdanie Zarządu Penta Poland z dnia 23 września 2019 r. uzasadniające Połączenie
M&A Activity Classification · 98% confidence The document is titled "SPRAWOZDANIE ZARZĄDU PENTA HOSPITALS POLAND SP. Z O.O. UZASADNIAJĄCE POŁĄCZENIE" (Management Report of Penta Hospitals Poland Sp. z o.o. Justifying the Merger). It extensively discusses the legal basis (referencing articles of the Polish Commercial Companies Code - KSH), the type of merger (merger by acquisition), the exchange ratio of shares/stakes, valuation methods used by Deloitte, and the economic rationale for the merger between EMC Instytut Medyczny S.A. and Penta Hospitals Poland sp. z o.o. This document is a detailed report justifying a corporate transaction (merger/takeover) as required by corporate law, which aligns closely with the scope of documents related to M&A activity (TAR) or potentially a specific type of management report related to a major transaction. Since the core content is the justification and details of a merger/takeover proposal, the most appropriate classification is M&A Activity (TAR). It is a detailed report, not just an announcement of a report (RPA/RNS).
2019-09-23 Polish
Sprawozdanie Zarządu Spółki z dnia 23 września 2019 r. uzasadniające Połączenie
M&A Activity Classification · 98% confidence The document is titled "SPRAWOZDANIE ZARZĄDU EMC INSTYTUT MEDYCZNY S.A. UZASADNIAJĄCE POŁĄCZENIE" (Management Board Report of EMC Instytut Medyczny S.A. Justifying the Merger). It extensively details the legal basis (referencing articles of the Polish Commercial Companies Code - KSH), the economic justification, the exchange ratio (Parytet Wymiany), and the valuation methods used by Deloitte for the merger between EMC Instytut Medyczny S.A. (acquiring company) and Penta Hospitals Poland sp. z o.o. (acquired company). This document is a formal report justifying a corporate transaction (merger/takeover) based on Polish corporate law, which aligns closely with the concept of a document detailing significant corporate actions or providing detailed management analysis related to such actions. While not a standard SEC filing like 10-K, its function is to provide the required justification for a merger, which falls under significant corporate/transactional reporting. Given the options, this detailed justification report for a merger/takeover proposal is best classified as related to M&A Activity (TAR), as it is the core document justifying the transaction outlined in the Merger Plan.
2019-09-23 Polish

Browse filings by year

10 years

Report missing filing

Can't find a specific document? Let us know and we'll add it within 24 hours.

We will notify you once the filing is added.
Report sent
Thank you. We will check the data and update it shortly.